Header Logo

Connection

SHELDON KAPLAN to Pneumococcal Infections

Back to Details
This is a "connection" page, showing publications SHELDON KAPLAN has written about Pneumococcal Infections.
SHELDON KAPLAN
Connection Strength
6.702
Pneumococcal Infections
  1. Invasive Pneumococcal Disease in Children's Hospitals: 2014-2017. Pediatrics. 2019 09; 144(3).
    View in: PubMed
    Score: 0.540
  2. Multicenter surveillance of Streptococcus pneumoniae isolates from middle ear and mastoid cultures in the 13-valent pneumococcal conjugate vaccine era. Clin Infect Dis. 2015 May 01; 60(9):1339-45.
    View in: PubMed
    Score: 0.395
  3. Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2013 Mar; 32(3):203-7.
    View in: PubMed
    Score: 0.345
  4. Pneumococcal disease caused by serotype 19A: review of the literature and implications for future vaccine development. Vaccine. 2010 Jun 11; 28(26):4249-59.
    View in: PubMed
    Score: 0.283
  5. Serotype 19A Is the most common serotype causing invasive pneumococcal infections in children. Pediatrics. 2010 Mar; 125(3):429-36.
    View in: PubMed
    Score: 0.280
  6. Serotype 19A is the most common Streptococcus pneumoniae isolate in children with chronic sinusitis. Pediatr Infect Dis J. 2009 Sep; 28(9):766-8.
    View in: PubMed
    Score: 0.271
  7. Recurrent systemic pneumococcal disease in children. Pediatr Infect Dis J. 2007 Jun; 26(6):480-4.
    View in: PubMed
    Score: 0.232
  8. Azithromycin compared with beta-lactam antibiotic treatment failures in pneumococcal infections of children. Pediatr Infect Dis J. 2004 May; 23(5):399-405.
    View in: PubMed
    Score: 0.187
  9. Pneumococcal endocarditis in children. Clin Infect Dis. 2004 May 01; 38(9):1273-8.
    View in: PubMed
    Score: 0.187
  10. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics. 2004 Mar; 113(3 Pt 1):443-9.
    View in: PubMed
    Score: 0.185
  11. Streptococcus pneumoniae infections in the neonate. Pediatrics. 2003 Nov; 112(5):1095-102.
    View in: PubMed
    Score: 0.181
  12. Decrease in Pediatric Invasive Pneumococcal Disease During the COVID-19 Pandemic. J Pediatric Infect Dis Soc. 2022 Sep 29; 11(9):426-428.
    View in: PubMed
    Score: 0.168
  13. Mechanisms of pneumococcal antibiotic resistance and treatment of pneumococcal infections in 2002. Pediatr Ann. 2002 Apr; 31(4):250-60.
    View in: PubMed
    Score: 0.162
  14. Invasive pneumococcal infections in children with asplenia. Pediatr Infect Dis J. 2002 Apr; 21(4):278-82.
    View in: PubMed
    Score: 0.162
  15. Six year multicenter surveillance of invasive pneumococcal infections in children. Pediatr Infect Dis J. 2002 Feb; 21(2):141-7.
    View in: PubMed
    Score: 0.160
  16. The Indirect Impact of the SARS-CoV-2 Pandemic on Invasive Group a Streptococcus, Streptococcus Pneumoniae and Staphylococcus Aureus Infections in Houston Area Children. Pediatr Infect Dis J. 2021 08 01; 40(8):e313-e316.
    View in: PubMed
    Score: 0.155
  17. Pneumococcal infections in children after transplantation. Clin Infect Dis. 2001 Jul 01; 33(1):16-21.
    View in: PubMed
    Score: 0.153
  18. Outcome of invasive infections outside the central nervous system caused by Streptococcus pneumoniae isolates nonsusceptible to ceftriazone in children treated with beta-lactam antibiotics. Pediatr Infect Dis J. 2001 Apr; 20(4):392-6.
    View in: PubMed
    Score: 0.151
  19. Prevention of pneumococcal respiratory infections. Pediatr Pulmonol. 2001; Suppl 23:82-5.
    View in: PubMed
    Score: 0.149
  20. Pneumococcal facial cellulitis in children. Pediatrics. 2000 Nov; 106(5):E61.
    View in: PubMed
    Score: 0.147
  21. Pneumococcal mastoiditis in children. Pediatrics. 2000 Oct; 106(4):695-9.
    View in: PubMed
    Score: 0.146
  22. Management of infections due to antibiotic-resistant Streptococcus pneumoniae. Clin Microbiol Rev. 1998 Oct; 11(4):628-44.
    View in: PubMed
    Score: 0.127
  23. Three-year multicenter surveillance of systemic pneumococcal infections in children. Pediatrics. 1998 Sep; 102(3 Pt 1):538-45.
    View in: PubMed
    Score: 0.126
  24. Invasive Pneumococcal Disease in Infants Aged 0-60 Days in the United States in the 13-Valent Pneumococcal Conjugate Vaccine Era. J Pediatric Infect Dis Soc. 2018 Aug 17; 7(3):249-252.
    View in: PubMed
    Score: 0.126
  25. Osteoarticular Infections Caused by Streptococcus pneumoniae in Children in the Post-Pneumococcal Conjugate Vaccine Era. Pediatr Infect Dis J. 2017 Dec; 36(12):1201-1204.
    View in: PubMed
    Score: 0.120
  26. Host defense against systemic infection with Streptococcus pneumoniae is impaired in E-, P-, and E-/P-selectin-deficient mice. J Clin Invest. 1997 Oct 15; 100(8):2099-106.
    View in: PubMed
    Score: 0.119
  27. Pneumococcal Pneumonia Requiring Hospitalization in US Children in the 13-Valent Pneumococcal Conjugate Vaccine Era. Clin Infect Dis. 2017 Jun 15; 64(12):1699-1704.
    View in: PubMed
    Score: 0.116
  28. Invasive pneumococcal infections in children following transplantation in the pneumococcal conjugate vaccine era. Transpl Infect Dis. 2017 Feb; 19(1).
    View in: PubMed
    Score: 0.113
  29. Emergence of Multidrug-Resistant Pneumococcal Serotype 35B among Children in the United States. J Clin Microbiol. 2017 03; 55(3):724-734.
    View in: PubMed
    Score: 0.111
  30. The emergence of resistant pneumococcus as a pathogen in childhood upper respiratory tract infections. Semin Respir Infect. 1995 Mar; 10(1):31-6.
    View in: PubMed
    Score: 0.099
  31. Impact of the 13-valent pneumococcal conjugate vaccine on chronic sinusitis associated with Streptococcus pneumoniae in children. Pediatr Infect Dis J. 2014 Oct; 33(10):1033-6.
    View in: PubMed
    Score: 0.096
  32. Penicillin-resistant systemic pneumococcal infections in children: a retrospective case-control study. Pediatrics. 1993 Dec; 92(6):761-7.
    View in: PubMed
    Score: 0.091
  33. Changes in Streptococcus pneumoniae serotype 19A invasive infections in children from 1993 to 2011. J Clin Microbiol. 2013 Apr; 51(4):1294-7.
    View in: PubMed
    Score: 0.086
  34. Characterization of nontypeable and atypical Streptococcus pneumoniae pediatric isolates from 1994 to 2010. J Clin Microbiol. 2012 Apr; 50(4):1326-30.
    View in: PubMed
    Score: 0.080
  35. Increase in prevalence of Streptococcus pneumoniae serotype 6C at Eight Children's Hospitals in the United States from 1993 to 2009. J Clin Microbiol. 2011 Jun; 49(6):2097-101.
    View in: PubMed
    Score: 0.076
  36. Pneumococcal mastoiditis in children and the emergence of multidrug-resistant serotype 19A isolates. Pediatrics. 2008 Jul; 122(1):34-9.
    View in: PubMed
    Score: 0.062
  37. Streptococcus pneumoniae serogroups 15 and 33: an increasing cause of pneumococcal infections in children in the United States after the introduction of the pneumococcal 7-valent conjugate vaccine. Pediatr Infect Dis J. 2006 Apr; 25(4):301-5.
    View in: PubMed
    Score: 0.053
  38. Effectiveness of abbreviated and delayed 7-valent pneumococcal conjugate vaccine dosing regimens. Vaccine. 2006 Mar 24; 24(14):2514-20.
    View in: PubMed
    Score: 0.052
  39. Acute otitis media due to penicillin-nonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis. 2005 Jun 15; 40(12):1738-44.
    View in: PubMed
    Score: 0.050
  40. The changing face of pleural empyemas in children: epidemiology and management. Pediatrics. 2004 Jun; 113(6):1735-40.
    View in: PubMed
    Score: 0.047
  41. Multinational study of pneumococcal serotypes causing acute otitis media in children. Pediatr Infect Dis J. 2002 Nov; 21(11):1008-16.
    View in: PubMed
    Score: 0.042
  42. Pneumococcal research transformed. N Engl J Med. 2001 Oct 18; 345(16):1206-7.
    View in: PubMed
    Score: 0.039
  43. The differential roles of LFA-1 and Mac-1 in host defense against systemic infection with Streptococcus pneumoniae. J Immunol. 2001 Jun 15; 166(12):7362-9.
    View in: PubMed
    Score: 0.038
  44. Acute otitis media caused by Streptococcus pneumoniae in children's hospitals between 1994 and 1997. Pediatr Infect Dis J. 2001 Jan; 20(1):34-9.
    View in: PubMed
    Score: 0.037
  45. Invasive Serotype 35B Pneumococci Including an Expanding Serotype Switch Lineage. Emerg Infect Dis. 2018 02; 24(2):405.
    View in: PubMed
    Score: 0.030
  46. Consensus: management of infections in children caused by Streptococcus pneumoniae with decreased susceptibility to penicillin. Pediatr Infect Dis J. 1995 Dec; 14(12):1037-41.
    View in: PubMed
    Score: 0.026
  47. Re: G. E. Schutze et al.: Resistant pneumococcus: a worldwide problem (Infection 22 [1994] 233-237) Infection. 1994 Sep-Oct; 22(5):361.
    View in: PubMed
    Score: 0.024
  48. Resistant Pneumococcus: a worldwide problem. Infection. 1994 Jul-Aug; 22(4):233-7.
    View in: PubMed
    Score: 0.024
  49. Increased rate of isolation of penicillin-resistant Streptococcus pneumoniae in a children's hospital and in vitro susceptibilities to antibiotics of potential therapeutic use. Antimicrob Agents Chemother. 1992 Aug; 36(8):1703-7.
    View in: PubMed
    Score: 0.021
  50. Factors associated with middle ear isolates of Streptococcus pneumoniae resistant to penicillin in a children's hospital. J Pediatr. 1991 Dec; 119(6):941-4.
    View in: PubMed
    Score: 0.020
  51. Macrolide resistance among middle ear isolates of Streptococcus pneumoniae observed at eight United States pediatric centers: prevalence of M and MLSB phenotypes. Pediatr Infect Dis J. 2003 Jul; 22(7):623-7.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.